- Home
- CLGN vs GTIM Comparison
CLGN vs GTIM Comparison
Compare CLGN & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- GTIM
- Stock Information
- Founded
- CLGN 2004
- GTIM 1987
- Country
- CLGN Israel
- GTIM United States
- Employees
- CLGN N/A
- GTIM N/A
- Industry
- CLGN Industrial Specialties
- GTIM Restaurants
- Sector
- CLGN Health Care
- GTIM Consumer Discretionary
- Exchange
- CLGN Nasdaq
- GTIM Nasdaq
- Market Cap
- CLGN 20.4M
- GTIM 17.1M
- IPO Year
- CLGN N/A
- GTIM 1990
- Fundamental
- Price
- CLGN $1.48
- GTIM $1.79
- Analyst Decision
- CLGN Strong Buy
- GTIM
- Analyst Count
- CLGN 2
- GTIM 0
- Target Price
- CLGN $11.50
- GTIM N/A
- AVG Volume (30 Days)
- CLGN 272.0K
- GTIM 13.4K
- Earning Date
- CLGN 08-19-2025
- GTIM 07-31-2025
- Dividend Yield
- CLGN N/A
- GTIM N/A
- EPS Growth
- CLGN N/A
- GTIM 65.30
- EPS
- CLGN N/A
- GTIM 0.09
- Revenue
- CLGN $2,472,000.00
- GTIM $144,322,000.00
- Revenue This Year
- CLGN $2,177.67
- GTIM N/A
- Revenue Next Year
- CLGN $56.52
- GTIM N/A
- P/E Ratio
- CLGN N/A
- GTIM $18.94
- Revenue Growth
- CLGN N/A
- GTIM 4.14
- 52 Week Low
- CLGN $1.40
- GTIM $1.51
- 52 Week High
- CLGN $5.48
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- CLGN 41.46
- GTIM 56.39
- Support Level
- CLGN $1.40
- GTIM $1.68
- Resistance Level
- CLGN $1.83
- GTIM $1.72
- Average True Range (ATR)
- CLGN 0.26
- GTIM 0.07
- MACD
- CLGN -0.08
- GTIM 0.02
- Stochastic Oscillator
- CLGN 4.11
- GTIM 95.87
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.